46
total announcements
MANKIND.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 21 Oct 2026
Market Cap
₹93,067 Cr
P/E (TTM)
45.6
P/E (Forward)
31.8
EPS (TTM)
₹49.42
52W Low
₹1,909.70
52W High
₹2,642.00
Dividend Yield
0.00%
Beta
0.45
Price / Book
5.7
Debt / Equity
38.1
Revenue (TTM)
₹14,738 Cr
Gross Margin
70.76%
Operating Margin
20.61%
Mankind Pharma Limited
Mankind Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming no dematerialisation/rematerialisation of shares for the quarter ended June 30, 2026.
Mankind Pharma Limited
Mankind Pharma Limited has informed the Exchange about a copy of a newspaper publication regarding the 35th Annual General Meeting (AGM) of the company, scheduled to be held on August 4, 2026, through video conferencing or other audio-visual means.
Mankind Pharma Limited
Mankind Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 04, 2026. The meeting will consider and adopt the Standalone Audited Financial Statements for the Financial Year ended March 31, 2026, and the Report of the Board of Directors and Auditors thereon. The meeting will also consider and if thought fit, pass resolutions for the re-appointment of Mr. Satish Kumar Sharma as Whole Time Director of the Company, and the ratification of the remuneration of Cost Auditors for the Financial Year 2026-27.
Mankind Pharma Limited
Mankind Pharma Limited has informed the Exchange about a newspaper advertisement regarding its 35th Annual General Meeting scheduled to be held on August 4, 2026.
Mankind Pharma Limited
Mankind Pharma Limited has scheduled its 35th Annual General Meeting (AGM) on August 4, 2026, through video conferencing. The notice and annual report for the financial year 2025-26 will be dispatched to members in due course.
Mankind Pharma Limited
Mankind Pharma Limited has informed the Exchange regarding the closure of the trading window for designated persons and their relatives due to the declaration of unaudited financial results for the quarter ending June 30, 2026.